Nirmatrelvir\/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID-19. It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer. Nirmatrelvir inhibits SARS-CoV-2 main protease, while ritonavir is a strong CYP3A inhibitor, slowing down nirmatrelvir metabolism and therefore boosting its effect.<\/p>\n
PAXLOVID (nirmatrelvir tablets; ritonavir) may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n Named-patient import facilitator contact details<\/strong> Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n Note:<\/strong><\/em> Paxlovid (nirmatrelvir co-packaged with ritonavir) is an oral antiviral medication used to treat mild-to-moderate COVID-19 in adults and adolescents (aged 12 and older, weighing at least 88 pounds\/40 kg) who are at high risk for progressing to severe illness, hospitalization, or death<\/p>\nHow to get PAXLOVID Tablets delivered in India?<\/h4>\n
Who can help source PAXLOVID Tablets in India legally?<\/h4>\n
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"Brand: PAXLOVID. API: nirmatrelvir tablets; ritonavir tablets is used to treat COVID-19.<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n PAXLOVID \u2013 On Request<\/strong><\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n nirmatrelvir tablets; ritonavir tablets<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 Tablets: nirmatrelvir 150 mg
\n\u2022 Tablets: ritonavir 100 mg<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n Pfizer Inc.<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n \n Get access to medicines:<\/strong><\/td>\n In India<\/td>\n<\/tr>\n \n Price:<\/strong><\/td>\n On Request<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n